Literature DB >> 21222065

Toxic effects of low alcohol and nicotine combinations in SH-SY5Y cells are apoptotically mediated.

Carlana Ramlochansingh1, Robert E Taylor, Yousef Tizabi.   

Abstract

It is well established that combination of heavy drinking and smoking has severe health consequences. However, at relatively low concentrations, both alcohol and nicotine may have beneficial effects including neuroprotection. Thus, protective effects of low alcohol concentration against beta-amyloid-induced toxicity in organotypic hippocampal slices and protective effects of nicotine against salsolinol-induced toxicity in human-derived neuroblastoma cells (SH-SY5Y) have been reported. In this study, we sought to determine whether alcohol might also be protective against salsolinol-induced toxicity in SH-SY5Y cells and whether the combination of low doses of alcohol and nicotine might have an additive or synergistic effect. Pre-exposure of SH-SY5Y cells to either ethanol (1 or 10 mM) or nicotine (20 or 50 μM) significantly attenuated salsolinol-induced toxicity. However, contrary to the expectation the combination of low doses of alcohol and nicotine not only did not provide any synergistic or additive protective effect, but exacerbated salsolinol-induced toxicity. Indeed, simple combination of low alcohol and nicotine resulted in significant toxicity in SH-SY5Y cells. This toxicity, reflected in a reduction in cell viability was associated with an increase in apoptosis as determined by caspase-3 measurement. These in vitro results suggest that combination of even low concentrations of alcohol and nicotine may activate apoptotic mechanisms that can lead to cell toxicity and detrimental consequences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21222065      PMCID: PMC3129456          DOI: 10.1007/s12640-011-9239-x

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  23 in total

1.  Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: implications for Parkinson's disease.

Authors:  Robert L Copeland; Yaminah A Leggett; Yasmine M Kanaan; Robert E Taylor; Yousef Tizabi
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

Review 2.  Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies.

Authors:  Michael A Collins; Edward J Neafsey; Kenneth J Mukamal; Mary O Gray; Dale A Parks; Dipak K Das; Ronald J Korthuis
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

Review 3.  Acute alcohol action and desensitization of ligand-gated ion channels.

Authors:  Alex M Dopico; David M Lovinger
Journal:  Pharmacol Rev       Date:  2009-03-06       Impact factor: 25.468

4.  Smoking cessation: How compelling is the evidence? A review.

Authors:  Philip Tønnesen
Journal:  Health Policy       Date:  2009-07       Impact factor: 2.980

5.  The interactive effect of alcohol and nicotine on NGF-treated pheochromocytoma cells.

Authors:  Andrew M Smith; Daniel R Zeve; Douglas P Dohrman; Wei-Jung A Chen
Journal:  Alcohol       Date:  2006-07-28       Impact factor: 2.405

Review 6.  Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease.

Authors:  Marina R Picciotto; Michele Zoli
Journal:  Front Biosci       Date:  2008-01-01

7.  Increased apoptosis and reduced neuronal and glial densities in the hippocampus due to nicotine and ethanol exposure in adolescent mice.

Authors:  Andreia Oliveira-da-Silva; Fernanda B Vieira; Fabiana Cristina-Rodrigues; Cláudio C Filgueiras; Alex C Manhães; Yael Abreu-Villaça
Journal:  Int J Dev Neurosci       Date:  2009-07-01       Impact factor: 2.457

Review 8.  Nicotine and Parkinson's disease: implications for therapy.

Authors:  Maryka Quik; Kathryn O'Leary; Caroline M Tanner
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

9.  Dietary habits, ethanol and tobacco consumption as predictive factors in the development of esophageal carcinoma in patients with head and neck neoplasms.

Authors:  A R A L Rossini; C L Hashimoto; K Iriya; C Zerbini; E R Baba; J P P Moraes-Filho
Journal:  Dis Esophagus       Date:  2008       Impact factor: 3.429

10.  Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells.

Authors:  Jharna R Das; Yousef Tizabi
Journal:  Neurotox Res       Date:  2009-03-20       Impact factor: 3.911

View more
  18 in total

Review 1.  Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.

Authors:  Laura L Hurley; Robert E Taylor; Yousef Tizabi
Journal:  Neurotox Res       Date:  2011-09-20       Impact factor: 3.911

2.  Protective effects of curcumin against rotenone and salsolinol-induced toxicity: implications for Parkinson's disease.

Authors:  Zakiya Qualls; Dwayne Brown; Carlana Ramlochansingh; Laura L Hurley; Yousef Tizabi
Journal:  Neurotox Res       Date:  2014-01       Impact factor: 3.911

Review 3.  Low Vs. High Alcohol: Central Benefits Vs. Detriments.

Authors:  Yousef Tizabi; Bruk Getachew; Clifford L Ferguson; Antonei B Csoka; Karl M Thompson; Alejandra Gomez-Paz; Jana Ruda-Kucerova; Robert E Taylor
Journal:  Neurotox Res       Date:  2018-01-04       Impact factor: 3.911

4.  Protective Effects of Donepezil Against Alcohol-Induced Toxicity in Cell Culture: Role of Caspase-3.

Authors:  Bruk Getachew; Tamaro Hudson; Thomas Heinbockel; Antonei B Csoka; Yousef Tizabi
Journal:  Neurotox Res       Date:  2018-05-26       Impact factor: 3.911

5.  PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.

Authors:  Dwayne Brown; Andrea Tamas; Dora Reglödi; Yousef Tizabi
Journal:  J Mol Neurosci       Date:  2013-04-28       Impact factor: 3.444

6.  PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells: Implications for Drinking-Smoking Co-morbidity.

Authors:  Sridharan Manavalan; Bruk Getachew; Kebreten F Manaye; Syed J Khundmiri; Antonei B Csoka; Raechel McKinley; Andrea Tamas; Dora Reglodi; Yousef Tizabi
Journal:  Neurotox Res       Date:  2017-03-24       Impact factor: 3.911

Review 7.  New strategies in neuroprotection and neurorepair.

Authors:  Marta C Antonelli; Gilles J Guillemin; Rita Raisman-Vozari; Elaine A Del-Bel; Michael Aschner; Michael A Collins; Yousef Tizabi; Rosario Moratalla; Adrian K West
Journal:  Neurotox Res       Date:  2011-08-23       Impact factor: 3.911

Review 8.  Duality of Antidepressants and Neuroprotectants.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2015-11-27       Impact factor: 3.911

9.  Nicotine promotes survival of cells expressing amyloid precursor protein and presenilin: implication for Alzheimer's disease.

Authors:  Dwayne Brown; Carlana Ramlochansingh; Kebreten F Manaye; Yousef Tizabi
Journal:  Neurosci Lett       Date:  2013-01-08       Impact factor: 3.046

10.  PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.

Authors:  Dwayne Brown; Andrea Tamas; Dora Reglodi; Yousef Tizabi
Journal:  Neurotox Res       Date:  2014-04-17       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.